Cargando…

Nature-inspired nanocarriers for improving drug therapy of atherosclerosis

Atherosclerosis (AS) has emerged as one of the prevalent arterial vascular diseases characterized by plaque and inflammation, primarily causing disability and mortality globally. Drug therapy remains the main treatment for AS. However, a series of obstacles hinder effective drug delivery. Nature, fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Weihong, Zhang, Yuanxing, Deng, Yuanru, Li, Changyong, Kankala, Ranjith Kumar, Chen, Aizheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460486/
https://www.ncbi.nlm.nih.gov/pubmed/37641591
http://dx.doi.org/10.1093/rb/rbad069
_version_ 1785097654790782976
author Ji, Weihong
Zhang, Yuanxing
Deng, Yuanru
Li, Changyong
Kankala, Ranjith Kumar
Chen, Aizheng
author_facet Ji, Weihong
Zhang, Yuanxing
Deng, Yuanru
Li, Changyong
Kankala, Ranjith Kumar
Chen, Aizheng
author_sort Ji, Weihong
collection PubMed
description Atherosclerosis (AS) has emerged as one of the prevalent arterial vascular diseases characterized by plaque and inflammation, primarily causing disability and mortality globally. Drug therapy remains the main treatment for AS. However, a series of obstacles hinder effective drug delivery. Nature, from natural micro-/nano-structural biological particles like natural cells and extracellular vesicles to the distinctions between the normal and pathological microenvironment, offers compelling solutions for efficient drug delivery. Nature-inspired nanocarriers of synthetic stimulus-responsive materials and natural components, such as lipids, proteins and membrane structures, have emerged as promising candidates for fulfilling drug delivery needs. These nanocarriers offer several advantages, including prolonged blood circulation, targeted plaque delivery, targeted specific cells delivery and controlled drug release at the action site. In this review, we discuss the nature-inspired nanocarriers which leverage the natural properties of cells or the microenvironment to improve atherosclerotic drug therapy. Finally, we provide an overview of the challenges and opportunities of applying these innovative nature-inspired nanocarriers.
format Online
Article
Text
id pubmed-10460486
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104604862023-08-28 Nature-inspired nanocarriers for improving drug therapy of atherosclerosis Ji, Weihong Zhang, Yuanxing Deng, Yuanru Li, Changyong Kankala, Ranjith Kumar Chen, Aizheng Regen Biomater Review Atherosclerosis (AS) has emerged as one of the prevalent arterial vascular diseases characterized by plaque and inflammation, primarily causing disability and mortality globally. Drug therapy remains the main treatment for AS. However, a series of obstacles hinder effective drug delivery. Nature, from natural micro-/nano-structural biological particles like natural cells and extracellular vesicles to the distinctions between the normal and pathological microenvironment, offers compelling solutions for efficient drug delivery. Nature-inspired nanocarriers of synthetic stimulus-responsive materials and natural components, such as lipids, proteins and membrane structures, have emerged as promising candidates for fulfilling drug delivery needs. These nanocarriers offer several advantages, including prolonged blood circulation, targeted plaque delivery, targeted specific cells delivery and controlled drug release at the action site. In this review, we discuss the nature-inspired nanocarriers which leverage the natural properties of cells or the microenvironment to improve atherosclerotic drug therapy. Finally, we provide an overview of the challenges and opportunities of applying these innovative nature-inspired nanocarriers. Oxford University Press 2023-08-11 /pmc/articles/PMC10460486/ /pubmed/37641591 http://dx.doi.org/10.1093/rb/rbad069 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Ji, Weihong
Zhang, Yuanxing
Deng, Yuanru
Li, Changyong
Kankala, Ranjith Kumar
Chen, Aizheng
Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
title Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
title_full Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
title_fullStr Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
title_full_unstemmed Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
title_short Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
title_sort nature-inspired nanocarriers for improving drug therapy of atherosclerosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460486/
https://www.ncbi.nlm.nih.gov/pubmed/37641591
http://dx.doi.org/10.1093/rb/rbad069
work_keys_str_mv AT jiweihong natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis
AT zhangyuanxing natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis
AT dengyuanru natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis
AT lichangyong natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis
AT kankalaranjithkumar natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis
AT chenaizheng natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis